omeprazole has been researched along with Uremia in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-risk peptic ulcer bleeding patients received endoscopic therapy with epinephrine (adrenaline) injection plus intravenous omeprazole (40 mg bolus followed by 40 mg infusion every 12 h) for 3 days." | 3.75 | Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study. ( Cheng, YT; Fang, CT; Huang, CH; Liao, PC; Lin, HJ; Tseng, GC; Tseng, GY; Wang, PC; Yang, HB, 2009) |
| " H2-receptors blocking drugs or gastric acidity buffers were withdrawn for 2 weeks, then omeprazole was administered for 4 weeks at a daily dosage of 20 mg." | 1.29 | Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study. ( Di Maggio, A; Franceschi, M; Loperfido, A; Montemurro, NE; Scatizzi, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Narayanan, R | 1 |
| Hoffmann, M | 1 |
| Surapaneni, S | 1 |
| Tseng, GY | 1 |
| Fang, CT | 1 |
| Lin, HJ | 1 |
| Yang, HB | 1 |
| Tseng, GC | 1 |
| Wang, PC | 1 |
| Liao, PC | 1 |
| Cheng, YT | 1 |
| Huang, CH | 1 |
| Seyyedmajidi, M | 1 |
| Falaknazi, K | 1 |
| Mirsattari, D | 1 |
| Zojaji, H | 1 |
| Roshani, M | 1 |
| Lahmi, F | 1 |
| Orimi, PG | 1 |
| Hadizadeh, M | 1 |
| Zali, M | 1 |
| Montemurro, NE | 1 |
| Di Maggio, A | 1 |
| Loperfido, A | 1 |
| Franceschi, M | 1 |
| Scatizzi, A | 1 |
| Nishitani, H | 1 |
| Kim, CW | 1 |
| Yamakawa, M | 1 |
| Nishizawa, Y | 1 |
| Morii, H | 1 |
1 trial available for omeprazole and Uremia
| Article | Year |
|---|---|
Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Creatinine; Dose-Response | 2011 |
4 other studies available for omeprazole and Uremia
| Article | Year |
|---|---|
The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes.
Topics: Adult; Aged; Cells, Cultured; Cytochrome P-450 CYP1A2; Dose-Response Relationship, Drug; Female; Hep | 2016 |
Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
Topics: Aged; Anti-Ulcer Agents; Blood Transfusion; Case-Control Studies; Drug Administration Schedule; Epin | 2009 |
Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study.
Topics: Adult; Drug Administration Schedule; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Peptic | 1993 |
[Upper gastrointestinal complications in uremic patients with dialysis].
Topics: Benzamidines; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Guanidines; H | 1992 |